Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients.
Alizargar J, Bai CH, Hsieh NC, Wu SV. · 2020
Read Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients. by Alizargar J, Bai CH, Hsieh NC, Wu SV. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6963998.txt.
Description
Alizargar and co-authors question a popular blood index in patients who already have heart disease. Their article appeared in Cardiovascular Diabetology. The triglyceride-glucose index, or TyG, combines two routine lab values. It serves as a stand-in marker for insulin resistance in healthy people.
A study they discuss linked higher TyG to more symptomatic coronary artery disease, and called it a marker of artery hardening. The authors urge caution. In patients with cardiovascular disease, diabetes and high blood fats themselves shape both parts of the index. That can bias its meaning. Splitting patients by disease category does not fix the problem, they argue. Nor does correlation prove causation. Before TyG guides care in such patients, its added value beyond the raw glucose and fat values must be shown.
Catalog record
| CREATOR | Alizargar J, Bai CH, Hsieh NC, Wu SV. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 9 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |